TAVI-in-TAVI in a patient after alcohol septal ablation

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00064203%3A_____%2F21%3A10437536" target="_blank" >RIV/00064203:_____/21:10437536 - isvavai.cz</a>

Nalezeny alternativní kódy

RIV/00216208:11130/21:10437536

Výsledek na webu

<a href="https://verso.is.cuni.cz/pub/verso.fpl?fname=obd_publikace_handle&handle=N-Ts0scK63" target="_blank" >https://verso.is.cuni.cz/pub/verso.fpl?fname=obd_publikace_handle&handle=N-Ts0scK63</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.5114/aic.2021.112525" target="_blank" >10.5114/aic.2021.112525</a>

Jazyk výsledku

angličtina

Název v původním jazyce

TAVI-in-TAVI in a patient after alcohol septal ablation

Popis výsledku v původním jazyce

Cardiovascular medicine at its beginning was dominated by surgical treatment options. The trend of the last decades is heading towards catheterization procedures. Alcohol septal ablation (ASA) was published by Sigwart in 1995 whereas transcatheter aortic valve implantation (TAVI) was performed in 2002 for the first time. Both methods have become efficient therapeutic options not only for patients not suitable for surgery but also for low-risk patients. Although the procedures are widely performed, certain challenges remain. Moreover, as patients get older, new difficulties emerge. We present a case of a patient with hypertrophic obstructive cardiomyopathy (HOCM) that was treated by ASA. Fifteen years later the patient developed severe aortic stenosis and was treated by TAVI that became severely stenotic 5 years later and required TAVI-in-TAVI implantation.

Název v anglickém jazyce

TAVI-in-TAVI in a patient after alcohol septal ablation

Popis výsledku anglicky

Cardiovascular medicine at its beginning was dominated by surgical treatment options. The trend of the last decades is heading towards catheterization procedures. Alcohol septal ablation (ASA) was published by Sigwart in 1995 whereas transcatheter aortic valve implantation (TAVI) was performed in 2002 for the first time. Both methods have become efficient therapeutic options not only for patients not suitable for surgery but also for low-risk patients. Although the procedures are widely performed, certain challenges remain. Moreover, as patients get older, new difficulties emerge. We present a case of a patient with hypertrophic obstructive cardiomyopathy (HOCM) that was treated by ASA. Fifteen years later the patient developed severe aortic stenosis and was treated by TAVI that became severely stenotic 5 years later and required TAVI-in-TAVI implantation.

Druh

J_imp - Článek v periodiku v databázi Web of Science

CEP obor

—

OECD FORD obor

30201 - Cardiac and Cardiovascular systems

Projekt

—

Návaznosti

I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Rok uplatnění

2021

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

Advances in Interventional Cardiology / Postępy w Kardiologii Interwencyjnej

ISSN

1734-9338

e-ISSN

—

Svazek periodika

17

Číslo periodika v rámci svazku

4

Stát vydavatele periodika

PL - Polská republika

Počet stran výsledku

2

Strana od-do

410-411

Kód UT WoS článku

000744962600002

EID výsledku v databázi Scopus

2-s2.0-85124137472